Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology

Field	Value	Language
dc.contributor.author	Tan, Ker-Kan	en
dc.contributor.author	Moran, Brendan J.	en
dc.contributor.author	Solomon, Michael J.	en
dc.date.accessioned	2020-05-27
dc.date.available	2020-05-27
dc.date.issued	2020	en
dc.identifier.uri	https://hdl.handle.net/2123/22368
dc.description.abstract	The coronavirus disease 19 (COVID-19) pandemic has become the focus of attention worldwide, and herein we seek to highlight the potential problem of ‘collateral mortality’ from delayed or deferred treatments in patients with cancer. We propose potential solutions to ensure continuity of care in the field of surgical oncology.	en
dc.language.iso	en	en
dc.rights	Other
dc.subject	COVID-19	en
dc.subject	Coronavirus	en
dc.title	Avoiding collateral mortality in a pandemic — time to change our mindset in surgical oncology	en
dc.type	Article	en
dc.identifier.doi	10.1038/s41571-020-0383-1
usyd.faculty	Faculty of Medicine and Health, Sydney Medical School	en

Associated file/s

There are no files associated with this item.